The next D&T Committee meeting will be held February 13, 2019
HFS will be reviewing the following classes for the February meeting:
Hematopoietic Agents
The agenda for the February meeting is full. All clinical and financial submissions for this meeting must be sent to the Department no later than 3pm CST on January 23, 2019. Any changes to drug status will become effective on or after April 1, 2019.